Qiagen NV

QIA: XETR (DEU)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|.nfLOCK|Th$!LOCK|X>qZW%Q

Qiagen Earnings: Strong Performance Across Key Segments; Raises Sales Guidance; Shares Fairly Valued

Qiagen reported third-quarter earnings with 5% organic growth and 6% growth on its core products, driven by a strong performance in its diagnostic solutions segment. Management raised its 2025 sales forecast to 4%-5%, up from 4%.

Sponsor Center